日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

通过合成剂量致死性鉴定 PLK1 过表达癌症的可靶向脆弱性

Cunningham Chelsea E, Vizeacoumar Frederick S, Zhang Yue, Kyrylenko Liliia, Both Simon, Maranda Vincent, Dong He, Price Jared D W, Gao Peng, Wagner Konrad, Wu Yingwen, Lazell-Wright Mary, Ganapathysamy Ashtalakshmi, Hari Rithik, Bhanumathy Kalpana K, Denomy Connor, Saxena Anjali, Vizeacoumar Jeff P, Morales Alain Morejon, Khan Faizaan, Mosley Shayla, Chen Angie, Katrii Tetiana, Zoller Ben G E, Rajamanickam Karthic, Walke Prachi, Gong Lihui, Patel Hardikkumar, Elhasasna Hussain, Dahiya Renuka, Abuhussein Omar, Dmitriev Anton, Freywald Tanya, Munhoz Erika Prando, Ruppin Eytan, Lee Joo Sang, Rox Katharina, Koebel Martin, Hopkins Laura, Lee Cheng Han, Yadav Sunil, Gasparoni Gilles, Walter Jörn, Krishnan Anand, Datla Raju, Toosi Behzad, Baker Kristi, Meens Jalna, Cescon David W, Ailles Laurie, Leary Scot C, Wu Yuliang, Empting Martin, Kiemer Alexandra K, Freywald Andrew, Vizeacoumar Franco J

Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial

一项开放标签、单臂临床试验,旨在评估重组新冠疫苗(ZF2001)作为异源加强疫苗在3-17岁健康儿童和青少年中,接种灭活疫苗后的免疫原性和安全性。

Huang, Tao; Hu, Qianqian; Zhou, Xiang; Yang, Huaiyu; Xia, Wei; Cao, Feng; Deng, Minglu; Teng, Xiaoxue; Ding, Fan; Zhong, Zaixin; Gao, Lidong; Sun, Jiufeng; Gong, Lihui